In preclinical studies, BMB-101 has demonstrated efficacy in animal models of epilepsy, binge eating, aggression, substance use disorder, and cognitive decline which highlights its potential for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback